Concepedia

Jôji Nagasawa

JN

Statistics

Publications

1

Citations

69

H-Index

1

Active since

2006

Affiliations

Kanazawa University(Current)

Jôji Nagasawa is an author at Kanazawa University specializing in her2 inhibitors, kidney cancer, and urologic oncology.

Publications per year

2006–2006

1

Publications

1

Novel HER2 selective tyrosine kinase inhibitor, TAK‐165, inhibits bladder, kidney and androgen‐independent prostate cancer <i>in vitro</i> and <i>in vivo</i>

Jôji Nagasawa, Atsushi Mizokami, Kiyoshi Koshida et al. · International Journal of Urology · 2006 · 69 citations · Full text

Medicine, Oncology, Pharmacology +15

1–1 of 1